Cefotaxime-d3-Cefotaxim-d-sub-3-sub-生命科學試劑-MCE-1932

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemECefotaxime-d3Cat.No.:HY-W654101Synonyms:Cefotaxim-d3;HR-756-d3分?式:C??H??D?N?O?S?分?量:458.48作?靶點:Isotope-LabeledCompounds;Antibiotic;Bacterial作?通路:Others;Anti-infection儲存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.溶解性數(shù)據(jù)體外實驗DMSO:250mg/mL(545.28mM;Needultrasonicandwarming)MassSolvent1mg5mg10mgConcentration制備儲備液1mM2.1811mL10.9056mL21.8112mL5mM0.4362mL2.1811mL4.3622mL10mM0.2181mL1.0906mL2.1811mLBIOLOGICALACTIVITY?物活性Cefotaxime-d3氘標記的Cefotaxime(HY-A0088A)。Cefotaxime耐β-內(nèi)酰胺酶穩(wěn)定的頭孢素和第三代頭孢素抗?素。Cefotaxime對多種?蘭?陽性和?蘭?性具有?譜抗?素活性。REFERENCES[1].RussakEM,etal.ImpactofDeuteriumSubstitutiononthePharmacokineticsofPharmaceuticals.AnnPharmacother.2019;53(2):211-216.[2].WoodfieldJC,etal.Acomparisonoftheprophylacticefficacyofceftriaxoneandcefotaximeinabdominalsurgery.AmJSurg.2003Jan;185(1):45-9.[3].ScholzH,etal.Prospectivecomparisonofceftriaxoneandcefotaximefortheshort-termtreatmentofbacterialmeningitisinchildren.1/2MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemEChemotherapy.1998Mar-Apr;44(2):142-7.[4].ELFrancke,etal.Useofcefotaxime,abeta-lactamasestablecephalosporin,inthetherapyofseriousinfections,includingthoseduetomultiresistantorganisms.AmJMed.1981Sep;71(3):435-42.[5].GumsJG,etal.Differencesbetweenceftriaxoneandcefotaxime:microbiologicalinconsistencies.AnnPharmacother.2008Jan;42(1):71-9.McePdfHeightCaution:Producthasnotbeenfullyvalidatedformedicalapplications.Forresearchuseonly.Tel:400-820-3792;021-5895